导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 10.39% | 115/354 |
| 近一周 | -1.22% | 74/356 |
| 近一月 | -1.49% | 113/362 |
| 近一季 | 1.33% | 125/362 |
| 近半年 | 13.15% | 135/358 |
| 近一年 | 12.46% | 140/349 |
| 近两年 | 26.01% | 201/314 |
| 近三年 | 47.46% | 109/244 |
| 成立以来 | 267.63% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.72% 115/360 |
14.30% 104/366 |
- - |
- - |
| 2025 | 10.49% 274/358 |
-0.19% 186/340 |
6.11% 176/348 |
3.84% 313/354 |
0.47% 160/358 |
| 2024 | 14.93% 170/329 |
6.57% 102/280 |
-0.10% 197/310 |
5.66% 149/318 |
2.17% 126/329 |
| 2023 | 13.35% 72/275 |
2.95% 86/205 |
4.24% 101/230 |
-4.19% 133/262 |
10.23% 90/276 |
| 2022 | -4.75% 24/201 |
-4.57% 29/153 |
-6.88% 83/164 |
-1.06% 50/189 |
8.33% 114/202 |
| 2021 | 18.89% 43/150 |
8.64% 36/312 |
5.13% 137/328 |
-0.67% 115/358 |
4.79% 62/151 |
| 2020 | 9.63% 42/103 |
-15.66% 195/280 |
11.87% 155/295 |
3.72% 115/299 |
12.02% 94/305 |
| 2019 | 21.29% 41/88 |
8.60% 147/258 |
4.44% 45/268 |
3.35% 58/253 |
3.48% 165/266 |
| 2018 | -3.64% 28/79 |
- - |
- - |
- - |
-11.64% 132/241 |
| 2017 | 8.32% 51/69 |
- - |
- - |
- - |
- - |
| 2016 | 13.18% 10/59 |
- - |
- - |
- - |
- - |
| 2015 | 2.33% 17/49 |
- - |
- - |
- - |
- - |
| 2014 | 9.10% 28/99 |
- - |
- - |
- - |
- - |
| 2013 | 24.67% 9/70 |
- - |
- - |
- - |
- - |
| 2012 | 11.42% 26/51 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 长信标普100等权重指数人民币 VS. 建信富时100指数(QDII)人民币A(539003) |